There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Liquidia Technologies Inc (LQDA) and BioTime (BTX) with bullish sentiments.
Liquidia Technologies Inc (LQDA)
Wedbush analyst Liana Moussatos reiterated a Buy rating on Liquidia Technologies Inc today and set a price target of $50. The company’s shares opened today at $9.04, close to its 52-week low of $8.01.
According to TipRanks.com, Moussatos is currently ranked with no stars on a 0-5 star ranking scale, with an average return of -8.6% and a 34.7% success rate. Moussatos covers the Healthcare sector, focusing on stocks such as BioMarin Pharmaceutical Inc., Allena Pharmaceuticals Inc, and Aquestive Therapeutics Inc.
Liquidia Technologies Inc has an analyst consensus of Moderate Buy, with a price target consensus of $49.
See today’s analyst top recommended stocks >>
BioTime (BTX)
Maxim Group analyst Jason McCarthy maintained a Buy rating on BioTime today and set a price target of $3. The company’s shares opened today at $1.28.
McCarthy commented:
“BioTime reported updated Phase 1/2a interim data for OpRegen, retinal pigment epithelium (RPE) cell transplant therapy in dry age-related macular degeneration (AMD) with geographic atrophy (GA) at the Association for Research in Vision and Ophthalmology (ARVO).”
According to TipRanks.com, McCarthy is currently ranked with no stars on a 0-5 star ranking scale, with an average return of -10.9% and a 29.3% success rate. McCarthy covers the Healthcare sector, focusing on stocks such as Teva Pharmaceutical Industries Limited, SELLAS Life Sciences Group Inc, and ContraVir Pharmaceuticals Inc.
Currently, the analyst consensus on BioTime is a Strong Buy with an average price target of $4, which is a 212.5% upside from current levels. In a report released today, H.C. Wainwright also reiterated a Buy rating on the stock with a $4 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
